The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome

NCT02431533 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pharmabiotix Inc

Collaborators